Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve As per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Norris Medicines Ltd has informed BSE that its Board of Directors will meet on Thursday, 14th August 2025 at the registered office in Ankleshwar, Gujarat. The main agenda is to consider and approve the unaudited financial results for the quarter ended 30th June 2025, along with the Limited Review Report. The trading window for dealing in the company's securities is already closed from 1st July 2025 and will remain closed until 48 hours after the results are declared. No specific financial figures or business decisions are disclosed in this intimation, as it is a standard advance notice under SEBI LODR Regulation 29.
This is a routine procedural filing with no direct impact on shareholders. Investors should watch for the actual Q1 FY26 results on 14th August, which could move the stock depending on performance versus expectations. The closed trading window also means insiders cannot trade until results are public.